These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 28765944)

  • 41. The metastasis suppressor, N-myc downstream regulated gene 1 (NDRG1), upregulates p21 via p53-independent mechanisms.
    Kovacevic Z; Sivagurunathan S; Mangs H; Chikhani S; Zhang D; Richardson DR
    Carcinogenesis; 2011 May; 32(5):732-40. PubMed ID: 21398495
    [TBL] [Abstract][Full Text] [Related]  

  • 42. FOXM1 expression in rhabdomyosarcoma: a novel prognostic factor and therapeutic target.
    Kuda M; Kohashi K; Yamada Y; Maekawa A; Kinoshita Y; Nakatsura T; Iwamoto Y; Taguchi T; Oda Y
    Tumour Biol; 2016 Apr; 37(4):5213-23. PubMed ID: 26553361
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Decreased growth of Vhl-/- fibrosarcomas is associated with elevated levels of cyclin kinase inhibitors p21 and p27.
    Mack FA; Patel JH; Biju MP; Haase VH; Simon MC
    Mol Cell Biol; 2005 Jun; 25(11):4565-78. PubMed ID: 15899860
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Constitutive activation of MET signaling impairs myogenic differentiation of rhabdomyosarcoma and promotes its development and progression.
    Skrzypek K; Kusienicka A; Szewczyk B; Adamus T; Lukasiewicz E; Miekus K; Majka M
    Oncotarget; 2015 Oct; 6(31):31378-98. PubMed ID: 26384300
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer.
    Gery S; Tanosaki S; Bose S; Bose N; Vadgama J; Koeffler HP
    Clin Cancer Res; 2005 May; 11(9):3184-90. PubMed ID: 15867211
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Msi1 promotes tumor growth and cell proliferation by targeting cell cycle checkpoint proteins p21, p27 and p53 in cervical carcinomas.
    Liu X; Yang WT; Zheng PS
    Oncotarget; 2014 Nov; 5(21):10870-85. PubMed ID: 25362645
    [TBL] [Abstract][Full Text] [Related]  

  • 47. LincRNA-p21 predicts favorable clinical outcome and impairs tumorigenesis in diffuse large B cell lymphoma patients treated with R-CHOP chemotherapy.
    Peng W; Wu J; Feng J
    Clin Exp Med; 2017 Feb; 17(1):1-8. PubMed ID: 26475621
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of novel genes expressed during rhabdomyosarcoma differentiation using cDNA microarrays.
    Carey KA; Segal D; Klein R; Sanigorski A; Walder K; Collier GR; Cameron-Smith D
    Pathol Int; 2006 May; 56(5):246-55. PubMed ID: 16669873
    [TBL] [Abstract][Full Text] [Related]  

  • 49. AP4 encodes a c-MYC-inducible repressor of p21.
    Jung P; Menssen A; Mayr D; Hermeking H
    Proc Natl Acad Sci U S A; 2008 Sep; 105(39):15046-51. PubMed ID: 18818310
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TBX2 represses PTEN in rhabdomyosarcoma and skeletal muscle.
    Zhu B; Zhang M; Williams EM; Keller C; Mansoor A; Davie JK
    Oncogene; 2016 Aug; 35(32):4212-24. PubMed ID: 26686089
    [TBL] [Abstract][Full Text] [Related]  

  • 51. c-Myc represses FOXO3a-mediated transcription of the gene encoding the p27(Kip1) cyclin dependent kinase inhibitor.
    Chandramohan V; Mineva ND; Burke B; Jeay S; Wu M; Shen J; Yang W; Hann SR; Sonenshein GE
    J Cell Biochem; 2008 Aug; 104(6):2091-106. PubMed ID: 18393360
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acylglycerol kinase promotes the proliferation and cell cycle progression of oral squamous cell carcinoma.
    Liu G; Ren X; Gao C; Zhang W
    Mol Med Rep; 2015 Aug; 12(2):2225-30. PubMed ID: 25872568
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modulation by phenylacetate of early estrogen-mediated events in MCF-7 breast cancer cells.
    Liu J; Li J; Sidell N
    Cancer Chemother Pharmacol; 2007 Feb; 59(2):217-25. PubMed ID: 16738884
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cetuximab promotes anticancer drug toxicity in rhabdomyosarcomas with EGFR amplification in vitro.
    Yamamoto Y; Fukuda K; Fuchimoto Y; Matsuzaki Y; Saikawa Y; Kitagawa Y; Morikawa Y; Kuroda T
    Oncol Rep; 2013 Sep; 30(3):1081-6. PubMed ID: 23828214
    [TBL] [Abstract][Full Text] [Related]  

  • 55. De-repression of the p21 promoter in prostate cancer cells by an isothiocyanate via inhibition of HDACs and c-Myc.
    Wang LG; Liu XM; Fang Y; Dai W; Chiao FB; Puccio GM; Feng J; Liu D; Chiao JW
    Int J Oncol; 2008 Aug; 33(2):375-80. PubMed ID: 18636159
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The gene expression index c-myc x E2F-1/p21 is highly predictive of malignant phenotype in human bronchial epithelial cells.
    DeMuth JP; Jackson CM; Weaver DA; Crawford EL; Durzinsky DS; Durham SJ; Zaher A; Phillips ER; Khuder SA; Willey JC
    Am J Respir Cell Mol Biol; 1998 Jul; 19(1):18-24. PubMed ID: 9651176
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel Roles for Staufen1 in Embryonal and Alveolar Rhabdomyosarcoma via c-myc-dependent and -independent events.
    Crawford Parks TE; Marcellus KA; Langill J; Ravel-Chapuis A; Michaud J; Cowan KN; Côté J; Jasmin BJ
    Sci Rep; 2017 Feb; 7():42342. PubMed ID: 28211476
    [TBL] [Abstract][Full Text] [Related]  

  • 58. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
    Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM
    Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CSIG promotes hepatocellular carcinoma proliferation by activating c-MYC expression.
    Cheng Q; Yuan F; Lu F; Zhang B; Chen T; Chen X; Cheng Y; Li N; Ma L; Tong T
    Oncotarget; 2015 Mar; 6(7):4733-44. PubMed ID: 25749381
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Miz-1 promotes the proliferation of esophageal cancer cells via suppression of p21 and release of p21-arrested cyclin D1.
    Luo J; Zhang C; Wang C; Li L; Li C; Li Q; Zhang M; Wu Q
    Oncol Rep; 2016 Jun; 35(6):3532-40. PubMed ID: 27109891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.